A bit of a delay to the previous timeline may keep the SP in check.
Targeting Phase I mid-2022 (roughly same time as TBI Phase I), compared to late 2021 previously mentioned.
Looking forward to hearing about the study design. Would be great if there is an expansion arm to the study (Ib or I/II), getting some efficacy data ($$$).
Ann: NYX-PCSK9i with Statin Achieves 65% Cholesterol Reduction, page-29
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $63.43M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.0¢ | $277.0K | 957.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31270 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 130414 | 1 |
View Market Depth
| Last trade - 15.54pm 07/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |